Unfortunately no-one is buying the product, it just does not resonate on any level. If it hasn't got any traction by now it never will
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025